LLY compared with ENSC: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ENSCEnsysce Biosciences, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ENSCEnsysce Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,371.31· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ENSCEnsysce Biosciences, Inc.

0.34▼−6.95%· post 0.34· delayed

After hoursNov 5 '26delayed

Mkt cap$7.2MRevenue$1,497Q4 FY23Revenue—

Compare

After hoursNov 5 '26delayed

LLYELI Lilly & Co

ENSCEnsysce Biosciences, Inc.

1,371.32▼−3.29%post 1,371.31delayed

Price

0.34▼−6.95%post 0.34delayed

$1.3T

Mkt cap

$7.2M

Q3 FY26$24.4B

Revenue

$1,497Q4 FY23

FY25$65.2B

Revenue

—

LLY1,371.32▼−3.29%vsENSC0.34▼−6.95%After hoursNov 5 '26delayed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No disclosed counterparties: ENSC.

Only ENSC 0

None

Role chip = supplier or customerSource: SEC EDGAR